The efficacy of single dose palonosetron in highly emetogenic chemotherapy protocols compared to oral aprepitant and ondansetron. Journal of Pharmacovigilance and Drug Research, [S. l.], v. 3, n. 3, p. 28–39, 2022. DOI: 10.53411/jpadr.2022.3.3.06. Disponível em: https://test.jpadr.com/index.php/jpadr/article/view/71. Acesso em: 13 oct. 2026.